Updated
Updated · Oncodaily · Oct 8
PICI Highlights Therapeutic Cancer Vaccines Across Multiple Cancers as Research Push Enters New Era
Updated
Updated · Oncodaily · Oct 8

PICI Highlights Therapeutic Cancer Vaccines Across Multiple Cancers as Research Push Enters New Era

3 articles · Updated · Oncodaily · Oct 8

Summary

  • Parker Institute for Cancer Immunotherapy said therapeutic cancer vaccines are entering a “new era,” citing encouraging results across multiple cancers and rising momentum to move them toward patients.
  • Kristen Dahlgren and Karen Knudsen discussed that shift with NBC News, pairing Dahlgren’s breast cancer experience with PICI’s effort to speed vaccine research.
  • PICI said the challenge is no longer only scientific, arguing that collaboration, coordination and funding will determine whether promising vaccine data becomes real cancer treatments.

Insights

With a lengthy production delay, can personalized mRNA cancer vaccines reach patients before their tumors aggressively return?
Could combining AI and nanotechnology be the secret to unlocking instant access to highly personalized cancer therapies?
If mRNA cancer vaccines finally work, why might the biggest hurdle be global supply chains instead of science?